Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.
Role of Adolescence in Drug Distribution and Effect
 |
NICHD Archive
Note: Information on this page was accurate at the time of publication.
This page is no longer being updated. |
May 1, 2019 (Noon–1 p.m. ET)
Sponsor/Co-Sponsor(s)
Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act, NICHD
Location
Webinar
Purpose
For this webinar, Michael D. Reed, Pharm.D., FCCP, FCP, will:
- Describe the effect of adolescence/puberty on drug disposition and effect.
- Identify sources of variability in drug disposition and effect during adolescence.
- Apply principles of drug pharmacokinetics and pharmacodynamics to determine optimal drug dosing in the adolescent patient.
Dr. Reed is professor emeritus of pediatrics at the Case Western Reserve University School of Medicine in Cleveland, Ohio.
Contact
George Giacoia, OPPTB, NICHD
Phone: 301–496–5589
Email: giacoiag@mail.nih.gov
Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.